|
1
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katahira J: Nuclear export of messenger
RNA. Genes (Basel). 6:163–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ebert MS and Sharp PA: Emerging roles for
natural microRNA sponges. Curr Biol. 20:R858–R861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Franco-Zorrilla JM, Valli A, Todesco M,
Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, García JA and
Paz-Ares J: Target mimicry provides a new mechanism for regulation
of microRNA activity. Nat Genet. 39:1033–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ala U, Karreth FA, Bosia C, Pagnani A,
Taulli R, Léopold V, Tay Y, Provero P, Zecchina R and Pandolfi PP:
Integrated transcriptional and competitive endogenous RNA networks
are cross-regulated in permissive molecular environments. Proc Natl
Acad Sci USA. 110:7154–7159. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arvey A, Larsson E, Sander C, Leslie CS
and Marks DS: Target mRNA abundance dilutes microRNA and siRNA
activity. Mol Syst Biol. 6:3632010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karreth FA, Tay Y, Perna D, Ala U, Tan SM,
Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al:
In vivo identification of tumor-suppressive PTEN ceRNAs in
an oncogenic BRAF-induced mouse model of melanoma. Cell.
147:382–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ling S, Birnbaum Y, Nanhwan MK, Thomas B,
Bajaj M, Li Y, Li Y and Ye Y: Dickkopf-1 (DKK1) phosphatase and
tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA
interference in the diabetic heart. Basic Res Cardiol. 108:3522013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang
Y, Yee AY, Li M, Du WW, Shatseva T and Yang BB: Expression of
versican 3′-untranslated region modulates endogenous microRNA
functions. PLoS One. 5:e135992010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee DY, Shatseva T, Jeyapalan Z, Du WW,
Deng Z and Yang BB: A 3′-untranslated region (3′UTR) induces organ
adhesion by regulating miR-199a* functions. PLoS One. 4:e45272009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang L, Du WW, Yang X, Chen K, Ghanekar A,
Levy G, Yang W, Yee AJ, Lu WY, Xuan JW, et al: Versican
3′-untranslated region (3′-UTR) functions as a ceRNA in inducing
the development of hepatocellular carcinoma by regulating miRNA
activity. FASEB J. 27:907–919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou
AG: DIANA-LncBase: Experimentally verified and computationally
predicted microRNA targets on long non-coding RNAs. Nucleic Acids
Res. 41:D239–D245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiyomaru T, Fukuhara S, Saini S, Majid S,
Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et
al: Long non-coding RNA HOTAIR is targeted and regulated by miR-141
in human cancer cells. J Biol Chem. 289:12550–12565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with micro RNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kallen AN, Zhou XB, Xu J, et al: The
imprinted H19 lncRNA antagonizes Let-7 microRNAs. Mol Cell.
52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harrison PM, Zheng D, Zhang Z, Carriero N
and Gerstein M: Transcribed processed pseudogenes in the human
genome: An intermediate form of expressed retrosequence lacking
protein-coding ability. Nucleic Acids Res. 33:2374–2383. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pink RC, Wicks K, Caley DP, Punch EK,
Jacobs L and Carter DR: Pseudogenes: Pseudo-functional or key
regulators in health and disease? RNA. 17:792–798. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
D'Errico I, Gadaleta G and Saccone C:
Pseudogenes in metazoa: Origin and features. Brief Funct Genomic
Proteomic. 3:157–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marques AC, Tan J, Lee S, Kong L, Heger A
and Ponting CP: Evidence for conserved post-transcriptional roles
of unitary pseudogenes and for frequent bifunctionality of mRNAs.
Genome Biol. 13:R1022012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Capel B, Swain A, Nicolis S, Hacker A,
Walter M, Koopman P, Goodfellow P and Lovell-Badge R: Circular
transcripts of the testis-determining gene Sry in adult mouse
testis. Cell. 73:1019–1030. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou X, Gao Q, Wang J, Zhang X, Liu K and
Duan Z: Linc-RNA-RoR acts as a ‘sponge’ against mediation of the
differentiation of endometrial cancer stem cells by microRNA-145.
Gynecol Oncol. 133:333–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Slaidina M and Lehmann R: Translational
control in germline stem cell Development. J Cell Biol. 207:13–21.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jeyapalan Z, Deng Z, Shatseva T, Fang L,
He C and Yang BB: Expression of CD44 3′-untranslated region
regulates endogenous microRNA functions in tumorigenesis and
angiogenesis. Nucleic Acids Res. 39:3026–3041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Voutilainen K, Anttila M, Sillanpää S,
Tammi R, Tammi M, Saarikoski S and Kosma VM: Versican in epithelial
ovarian cancer: Relation to hyaluronan, clinicopathologic factors
and prognosis. Int J Cancer. 107:359–364. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Herrlich P, Morrison H, Sleeman J,
Orian-Rousseau V, König H, Weg-Remers S and Ponta H: CD44 acts both
as a growth- and invasiveness-promoting molecule and as a
tumor-suppressing cofactor. Ann NY Acad Sci. 910:106–118. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kumar MS, Armenteros-Monterroso E, East P,
Chakravorty P, Matthews N, Winslow MM and Downward J: HMGA2
functions as a competing endogenous RNA to promote lung cancer
progression. Nature. 505:212–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Di Cello F, Hillion J, Hristov A, Wood LJ,
Mukherjee M, Schuldenfrei A, Kowalski J, Bhattacharya R, Ashfaq R
and Resar LM: HMGA2 participates in transformation in human lung
cancer. Mol Cancer Res. 6:743–750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meyer B, Loeschke S, Schultze A, Weigel T,
Sandkamp M, Goldmann T, Vollmer E and Bullerdiek J: HMGA2
overexpression in non-small cell lung cancer. Mol Carcinog.
46:503–511. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Winslow MM, Dayton TL, Verhaak RG,
Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ,
Whittaker CA, Hoersch S, et al: Suppression of lung adenocarcinoma
progression by Nkx2-1. Nature. 473:101–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Endo H, Shiroki T, Nakagawa T, Yokoyama M,
Tamai K, Yamanami H, Fujiya T, Sato I, Yamaguchi K, Tanaka N, et
al: Enhanced expression of long non-coding RNA HOTAIR is associated
with the development of gastric cancer. PLoS One. 8:e770702013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hajjari M, Behmanesh M, Sadeghizadeh M and
Zeinoddini M: Up-regulation of HOTAIR long non-coding RNA in human
gastric adenocarcinoma tissues. Med Oncol. 30:6702013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
van der Wal JE, Hermsen MA, Gille HJ,
Schouten-Van Meeteren NY, Moll AC, Imhof SM, Meijer GA, Baak JP and
van der Valk P: Comparative genomic hybridisation divides
retinoblastomas into a high and a low level chromosomal instability
group. J Clin Pathol. 56:26–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zimonjic DB, Keck CL, Thorgeirsson SS and
Popescu NC: Novel recurrent genetic imbalances in human
hepatocellular carcinoma cell lines identified by comparative
genomic hybridization. Hepatology. 29:1208–1214. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Plantaz D, Mohapatra G, Matthay KK,
Pellarin M, Seeger RC and Feuerstein BG: Gain of chromosome 17 is
the most frequent abnormality detected in neuroblastoma by
comparative genomic hybridization. Am J Pathol. 150:81–89.
1997.PubMed/NCBI
|
|
51
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vandewalle C, Comijn J, De Craene B,
Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F and
Berx G: SIP1/ZEB2 induces EMT by repressing genes of different
epithelial cell-cell junctions. Nucleic Acids Res. 33:6566–6578.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013.PubMed/NCBI
|
|
55
|
Loewer S, Cabili MN, Guttman M, Loh YH,
Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, et al:
Large intergenic non-coding RNA-RoR modulates reprogramming of
human induced pluripotent stem cells. Nat Genet. 42:1113–1117.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao
L, Wu M, Xiong J, Guo X and Liu H: Endogenous miRNA sponge
lincRNA-RoR regulates Oct4, Nanog and Sox2 in human embryonic stem
cell self-renewal. Dev Cell. 25:69–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rutnam ZJ and Yang BB: The non-coding
3′UTR of CD44 induces metastasis by regulating extracellular matrix
functions. J Cell Sci. 125:2075–2085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Waalkes S, Atschekzei F, Kramer MW,
Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS,
Schrader AJ, Kuczyk MA and Serth J: Fibronectin 1 mRNA expression
correlates with advanced disease in renal cancer. BMC Cancer.
10:5032010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ji J, Zhao L, Budhu A, Forgues M, Jia HL,
Qin LX, Ye QH, Yu J, Shi X, Tang ZY and Wang XW: Let-7g targets
collagen type I alpha2 and inhibits cell migration in
hepatocellular carcinoma. J Hepatol. 52:690–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ferrara N: Vascular endothelial growth
factor. Arterioscler Thromb Vasc Biol. 29:789–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer
A, Llobet-Navas D, Rajbhandari P, Bansal M, Guarnieri P, Silva J
and Califano A: An extensive microRNA-mediated network of RNA-RNA
interactions regulates established oncogenic pathways in
glioblastoma. Cell. 147:370–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Giovannetti E, Erozenci A, Smit J, Danesi
R and Peters GJ: Molecular mechanisms underlying the role of
microRNAs (miRNAs) in anticancer drug resistance and implications
for clinical practice. Crit Rev Oncol Hematol. 81:103–122. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Allen KE and Weiss GJ: Resistance may not
be futile: MicroRNA biomarkers for chemoresistance and potential
therapeutics. Mol Cancer Ther. 9:3126–3136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Cho WC: MicroRNAs: Potential biomarkers
for cancer diagnosis, prognosis and targets for therapy. Int J
Biochem Cell Biol. 42:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cho WC: MicroRNAs in cancer-from research
to therapy. Biochim Biophys Acta. 1805:209–217. 2010.PubMed/NCBI
|
